Repligen Corp.
RGEN
Market Cap$6.92B
Close$
$52.10
60.4% downside
Current Fair Value
60.4% downsideOvervalued by 60.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.92 Billion |
|---|---|
| Enterprise Value | $6.76 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.46 |
| Beta | 1.21 |
| Outstanding Shares | 56,123,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -272.61 |
|---|---|
| PEG | -152.79 |
| Price to Sales | 11.96 |
| Price to Book Ratio | 3.76 |
| Enterprise Value to Revenue | 10.46 |
| Enterprise Value to EBIT | 332.04 |
| Enterprise Value to Net Income | -1033 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Repligen Corp.
CEO: Anthony Hunt